As part of its education program titled, Returning to Practice in the Post-COVID-19 Era: Resources for Treating CLL, the Association of Cancer Care Centers (ACCC) is seeking an oncologist to participate in a 30-minute key informant interview to share their experience with managing patients with CLL in the COVID-19/post-COVID-19 era. ACCC will highlight findings from the interviews in a whitepaper on treating CLL in the pandemic era. The interviewee will receive a $100 honorarium.
If interested, please contact Program Manager, Limaya Atembina at latembina@accc-cancer.org. You may also fill out the Volunteer Registry Form by clicking "Apply Now" below and indicating "CLL Interview" when asked if a specific opportunity interests you.
Apply now
Understanding both the benefits to be had from offering BsAb therapy to its community and the scope of this undertaking, Vanderbilt-Ingram Cancer Center took a novel approach with its APP-led BsAb step-up dosing clinic, which won the program a 2026 ACCC Innovator Award.
